The use of the versatile N-heterocyclic carbene (NHC) gold(I) hydroxide [Au(OH)(IPr)] (IPr = N, N ′-bis(2,6-diisopropylphenyl)imidazol-2-ylidene) as precursor permits the expedient synthesis of a series of cationic heteroleptic [Au(NHC)(NHC′)] + and [Au(NHC)(PR 3 )] + complexes by protonolysis with the appropriate acid salts. Complete characterization by 1 H and 13 C NMR spectroscopy and by single-crystal X-ray diffraction was performed in order to discern electronic and structural differences between cationic heteroleptic [Au(NHC)(NHC′)] + and [Au(NHC)(PR 3 )] + congeners.
No takes yet. Share an insight, caveat, or question.
Gaillard et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: